A 33-year-old woman presents to her primary care provider for a normal check-up. She reports she has been feeling intermittently fatigued over the past 3 months, but she attributes it to her work as a corporate lawyer and balancing family life. She is otherwise healthy and takes no medications. She was adopted and has no information about her biological family. She has 2 children and has been married for 7 years. She drinks 4-5 glasses of wine per week and does not smoke. Her temperature is 99.2°F (37.3°C), blood pressure is 125/65 mmHg, pulse is 78/min, and respirations are 18/min. On exam, she is well-appearing and in no acute distress. A complete blood count is within normal limits. Additional workup is shown below:
Serum:
Na+: 139 mEq/L
Cl-: 99 mEq/L
K+: 3.9 mEq/L
HCO3-: 23 mEq/L
BUN: 18 mg/dL
Glucose: 110 mg/dL
Creatinine: 1.1 mg/dL
Ca2+: 11.1 mg/dL
Parathyroid hormone: 700 pg/mL
Urine:
Na+: 100 mEq/L/24h
Ca2+: 100 mg/24h
Osmolality: 400 mOsmol/kg H2O
Which of the following is the most likely underlying cause of this patient's condition?
Q12
A couple brings their 1-year-old child to a medical office for a follow-up evaluation of his small, empty scrotum. The scrotum has been empty since birth and the physician asked them to follow up with a pediatrician. There are no other complaints. The immunization history is up to date and his growth and development have been excellent. On examination, he is a playful, active child with a left, non-reducible, non-tender inguinal mass, an empty and poorly rugated hemiscrotal sac, and a testis within the right hemiscrotal sac. Which of the following hormones would likely be deficient in this patient by puberty if the condition is left untreated?
Q13
A 25-year-old woman comes to the physician for a pre-employment examination. Her current medications include an oral contraceptive and a daily multivitamin. Physical examination is unremarkable. Serum studies show calcium of 11.8 mg/dL, phosphorus of 2.3 mg/dL, and parathyroid hormone level of 615 pg/mL. A 24-hour urine collection shows a low urinary calcium level. Which of the following is the most likely underlying cause of this patient’s laboratory findings?
Q14
Activation of the renin-angiotensin-aldosterone system yields a significant physiological effect on renal blood flow and filtration. Which of the following is most likely to occur in response to increased levels of Angiotensin-II?
Q15
A 41-year-old female complains of frequent diarrhea and abdominal pain between meals. Endoscopy reveals a duodenal ulcer distal to the duodenal bulb. CT scan of the abdomen demonstrates a pancreatic mass, and subsequent tissue biopsy of the pancreas reveals a malignant islet cell tumor. Which of the following hormones is likely to be markedly elevated in this patient:
Q16
A 16-year-old male presents to his pediatrician concerned that he is not maturing like his friends. He has a history of cleft palate status-post multiple surgeries and asthma treated with budesonide and albuterol. He is a good student and is very active on his school’s gymnastics team. His mother is also concerned that her son does not understand good personal hygiene. She reports that he always forgets to put on deodorant. When asked about this, he says he does not notice any body odor on himself or others. His temperature is 99.2°F (37.3°C), blood pressure is 105/70 mmHg, pulse is 70/min, and respirations are 18/min. His height and weight are in the 20th and 25th percentiles, respectively. On physical examination, his penis and testicles show no evidence of enlargement. He has no pubic or axillary hair. Which of the following sets of hormone levels is most likely to be found in this patient?
Q17
A 55-year-old woman with rheumatoid arthritis comes to the physician because of a 3-month history of worsening fatigue and dyspnea. She has felt short-of-breath when walking up the stairs to her apartment. Menopause occurred 5 years ago. Her medications are methotrexate and folic acid supplementation. Physical examination shows conjunctival pallor, tenderness of bilateral wrists and knees, and ulnar deviation of the fingers. Her hematocrit is 27%, mean corpuscular volume is 84 μm3, and serum ferritin is 375 ng/mL. Which of the following has most likely contributed to the patient's current symptoms?
Q18
A 42-year-old woman presents with fatigue. She says that her symptoms have gradually onset after she recently had a total thyroidectomy due to Graves' disease. Past medical history is otherwise unremarkable. The patient is afebrile, and her vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings are significant for the following:
Potassium 4.2 mEq/L
Calcium 7.8 mg/dL
Chloride 102 mEq/L
Vitamin D3 8 ng/mL (ref range: 25–80 ng/mL)
A deficiency of which of the following is the most likely cause of this patient's symptoms?
Q19
A 57-year-old man is rushed to the emergency department by ambulance after being found on the floor gasping for air with severe shortness of breath by his partner. Past medical history is significant for congestive heart failure, hypertension, and hyperlipidemia. He normally takes chlorthalidone, atorvastatin, metoprolol, and valsartan, but he recently lost his job and insurance and has not been able to afford his medication in 2 months. Upon arrival at the hospital, his blood pressure is 85/50 mm Hg, heart rate is 110/min, respiratory rate is 24/min, oxygen saturation 90% on 100% oxygen, and temperature is 37.7°C (99.9°F). On physical exam, he appears obese and can only answer questions in short gasps as he struggles to breathe. His heart rate is tachycardic with a mildly irregular rhythm and auscultation of his lungs reveal crackles in the lower lobes, bilaterally. Which of the following physiologic changes is currently seen in this patient?
Q20
A 58-year-old Caucasian woman visits her primary care physician for an annual check-up. She has a history of type 2 diabetes mellitus and stage 3A chronic kidney disease. Her estimated glomerular filtration rate has not changed since her last visit. Today, her parathyroid levels are moderately elevated. She lives at home with her husband and 2 children and works as a bank clerk. Her vitals are normal, and her physical examination is unremarkable. Which of the following explains this new finding?
RAAS US Medical PG Practice Questions and MCQs
Question 11: A 33-year-old woman presents to her primary care provider for a normal check-up. She reports she has been feeling intermittently fatigued over the past 3 months, but she attributes it to her work as a corporate lawyer and balancing family life. She is otherwise healthy and takes no medications. She was adopted and has no information about her biological family. She has 2 children and has been married for 7 years. She drinks 4-5 glasses of wine per week and does not smoke. Her temperature is 99.2°F (37.3°C), blood pressure is 125/65 mmHg, pulse is 78/min, and respirations are 18/min. On exam, she is well-appearing and in no acute distress. A complete blood count is within normal limits. Additional workup is shown below:
Serum:
Na+: 139 mEq/L
Cl-: 99 mEq/L
K+: 3.9 mEq/L
HCO3-: 23 mEq/L
BUN: 18 mg/dL
Glucose: 110 mg/dL
Creatinine: 1.1 mg/dL
Ca2+: 11.1 mg/dL
Parathyroid hormone: 700 pg/mL
Urine:
Na+: 100 mEq/L/24h
Ca2+: 100 mg/24h
Osmolality: 400 mOsmol/kg H2O
Which of the following is the most likely underlying cause of this patient's condition?
A. Over-secretion of parathyroid hormone
B. Decreased sensitivity to parathyroid hormone
C. Gain-of-function mutation in the parathyroid hormone receptor gene
D. Impaired tubular calcium reabsorption
E. Loss-of-function mutation in the calcium-sensing receptor (Correct Answer)
Explanation: ***Loss-of-function mutation in the calcium-sensing receptor***
- The patient presents with **hypercalcemia** (Ca2+ 11.1 mg/dL) and **elevated parathyroid hormone (PTH)** (700 pg/mL), which is inappropriate given the high calcium. This combination is highly suggestive of **familial hypocalciuric hypercalcemia (FHH)**.
- FHH is caused by an inactivating mutation in the **calcium-sensing receptor (CaSR)**, leading to a "reset" of the calcium set point. The parathyroid glands and renal tubules perceive normal calcium levels as low, resulting in increased PTH secretion and increased renal tubular calcium reabsorption, despite hypercalcemia.
*Over-secretion of parathyroid hormone*
- While PTH is elevated, simply stating "over-secretion" doesn't explain why this is occurring in the setting of hypercalcemia, which should normally suppress PTH.
- This option would typically describe **primary hyperparathyroidism**, but the urinary calcium excretion in this patient (100 mg/24h) is in the low-normal range for hypercalcemia, making FHH a more likely diagnosis than primary hyperparathyroidism.
*Decreased sensitivity to parathyroid hormone*
- **Decreased sensitivity to PTH** would typically lead to **hypocalcemia** or normal calcium levels, not the hypercalcemia seen in this patient.
- Conditions like **pseudohypoparathyroidism** involve PTH resistance but present with hypocalcemia and hyperphosphatemia.
*Gain-of-function mutation in the parathyroid hormone receptor gene*
- A **gain-of-function mutation** in the PTH receptor would lead to enhanced sensitivity to PTH, causing **hypercalcemia** and **hypophosphatemia**.
- However, the PTH level would typically be **suppressed or low** due to feedback inhibition from hypercalcemia, which is contrary to the elevated PTH seen in this patient.
*Impaired tubular calcium reabsorption*
- **Impaired tubular calcium reabsorption** would lead to **hypercalciuria** (high urinary calcium) and likely normal or low serum calcium as calcium is excessively excreted.
- This patient exhibits relatively **low urinary calcium excretion** (100 mg/24h) despite hypercalcemia, which is characteristic of FHH.
Question 12: A couple brings their 1-year-old child to a medical office for a follow-up evaluation of his small, empty scrotum. The scrotum has been empty since birth and the physician asked them to follow up with a pediatrician. There are no other complaints. The immunization history is up to date and his growth and development have been excellent. On examination, he is a playful, active child with a left, non-reducible, non-tender inguinal mass, an empty and poorly rugated hemiscrotal sac, and a testis within the right hemiscrotal sac. Which of the following hormones would likely be deficient in this patient by puberty if the condition is left untreated?
A. LH
B. Testosterone (Correct Answer)
C. FSH
D. Inhibin
E. Prolactin
Explanation: ***Testosterone***
- **Testosterone** is produced by the **Leydig cells** in the testes. In untreated cryptorchidism, the elevated temperature in the inguinal canal causes progressive damage to both Sertoli cells and **Leydig cells** over time.
- By **puberty**, if left untreated for 11-13 years, the undescended testis will have significant irreversible Leydig cell dysfunction, leading to **reduced testosterone production**.
- While unilateral cryptorchidism may allow the contralateral descended testis to partially compensate, this compensation is often **incomplete during the high testosterone demands of puberty**, resulting in relative testosterone deficiency.
- This is the most clinically significant hormonal deficiency that develops with prolonged untreated cryptorchidism.
*LH*
- **Luteinizing hormone (LH)** is produced by the anterior pituitary and stimulates Leydig cells to produce testosterone. In cryptorchidism with resulting testosterone deficiency, LH levels would be **elevated** (not deficient) as a compensatory response.
- The pituitary responds normally to low testosterone with increased LH secretion via loss of negative feedback.
*Inhibin*
- **Inhibin** is produced by **Sertoli cells** in the seminiferous tubules. While cryptorchidism impairs Sertoli cell function and spermatogenesis, inhibin itself is not typically **deficient**.
- The primary consequence is **impaired spermatogenesis**, which leads to reduced negative feedback and **elevated FSH** levels, but inhibin levels may remain normal or only modestly reduced.
*FSH*
- **Follicle-stimulating hormone (FSH)** is produced by the anterior pituitary. In cryptorchidism, FSH is typically **elevated** (not deficient) due to impaired Sertoli cell function and loss of negative feedback from the seminiferous tubules.
- Elevated FSH is a marker of tubular dysfunction but is not itself deficient.
*Prolactin*
- **Prolactin** is produced by the anterior pituitary and primarily regulates lactation. It has no direct role in testicular function or the pathophysiology of cryptorchidism.
- There is no association between cryptorchidism and prolactin deficiency.
Question 13: A 25-year-old woman comes to the physician for a pre-employment examination. Her current medications include an oral contraceptive and a daily multivitamin. Physical examination is unremarkable. Serum studies show calcium of 11.8 mg/dL, phosphorus of 2.3 mg/dL, and parathyroid hormone level of 615 pg/mL. A 24-hour urine collection shows a low urinary calcium level. Which of the following is the most likely underlying cause of this patient’s laboratory findings?
A. Extrarenal calcitriol production
B. Impaired phosphate excretion
C. Hyperplasia of parathyroid chief cells
D. IL-1-induced osteoclast activation
E. Defect in calcium-sensing receptors (Correct Answer)
Explanation: ***Defect in calcium-sensing receptors***
- The constellation of **hypercalcemia**, **low urinary calcium**, **elevated PTH**, and **hypophosphatemia** is highly suggestive of **Familial Hypocalciuric Hypercalcemia (FHH)**, which is caused by an inactivating defect in calcium-sensing receptors (CaSR) in the parathyroid glands and renal tubules.
- In FHH, the parathyroid glands misinterpret the elevated serum calcium as normal or low, leading to **inappropriately high PTH secretion**, while the kidneys excessively reabsorb calcium due to defective CaSRs, resulting in low urinary calcium excretion.
*Extrarenal calcitriol production*
- This would cause **hypercalcemia** and **hyperphosphatemia** due to increased intestinal absorption of both calcium and phosphate.
- **PTH levels** would typically be suppressed, not elevated, in response to hypercalcemia.
*Impaired phosphate excretion*
- This would lead to **hyperphosphatemia**, not the **hypophosphatemia** observed in the patient.
- While hyperphosphatemia can indirectly affect calcium, it does not directly explain the high PTH in the presence of hypercalcemia and low urinary calcium.
*Hyperplasia of parathyroid chief cells*
- Parathyroid chief cell hyperplasia leads to **primary hyperparathyroidism**, characterized by **hypercalcemia**, **elevated PTH**, and typically **hypercalciuria** (high urinary calcium) due to PTH's actions on the kidney, unlike the low urinary calcium seen in this patient.
- While PTH is elevated and calcium is high, the distinguishing feature here is the **low urinary calcium**, which rules out typical primary hyperparathyroidism.
*IL-1-induced osteoclast activation*
- This mechanism is seen in the **humoral hypercalcemia of malignancy (HHM)**, often due to parathyroid hormone-related protein (PTHrP) secretion or cytokine release by tumors.
- In HHM, **PTH levels** would be suppressed, and **phosphate would be normal or low**, but the hallmark is the absence of elevated PTH and often very high calcium, which doesn't match this patient's profile.
Question 14: Activation of the renin-angiotensin-aldosterone system yields a significant physiological effect on renal blood flow and filtration. Which of the following is most likely to occur in response to increased levels of Angiotensin-II?
A. Decreased renal plasma flow, decreased filtration fraction
B. Decreased renal plasma flow, increased glomerular capillary oncotic pressure
C. Increased renal plasma flow, decreased filtration fraction
D. Increased renal plasma flow, increased filtration fraction
E. Decreased renal plasma flow, increased filtration fraction (Correct Answer)
Explanation: ***Decreased renal plasma flow, increased filtration fraction***
- **Angiotensin II** causes **efferent arteriolar constriction**, which reduces blood flow leaving the glomerulus, thereby **decreasing renal plasma flow**.
- This efferent constriction also increases **glomerular hydrostatic pressure** and reduces plasma flow distal to the glomerulus, leading to a **higher filtration fraction** (GFR/RPF).
*Decreased renal plasma flow, decreased filtration fraction*
- While **renal plasma flow decreases**, a **decreased filtration fraction** would imply that either GFR decreases disproportionately more than RPF or GFR does not increase despite the RPF reduction, which is not the typical response to **angiotensin II** due to its predominant effect on the **efferent arteriole**.
*Decreased renal plasma flow, increased glomerular capillary oncotic pressure*
- **Increased glomerular capillary oncotic pressure** is a consequence of increased filtration fraction, as more fluid is filtered out, leaving behind a more concentrated plasma. This option includes a correct element (decreased RPF) but pairs it with a less direct and defining outcome of acute Angiotensin II action as the primary physiological effect.
*Increased renal plasma flow, decreased filtration fraction*
- **Angiotensin II** causes **vasoconstriction**, predominantly of the efferent arteriole, which by definition would **decrease renal plasma flow**, not increase it.
- A **decreased filtration fraction** would be inconsistent with efferent arteriolar constriction which typically raises GFR relative to RPF.
*Increased renal plasma flow, increased filtration fraction*
- **Angiotensin II** causes **vasoconstriction**, leading to a **decrease in renal plasma flow**, not an increase.
- While **filtration fraction is increased**, the initial premise of increased renal plasma flow is incorrect.
Question 15: A 41-year-old female complains of frequent diarrhea and abdominal pain between meals. Endoscopy reveals a duodenal ulcer distal to the duodenal bulb. CT scan of the abdomen demonstrates a pancreatic mass, and subsequent tissue biopsy of the pancreas reveals a malignant islet cell tumor. Which of the following hormones is likely to be markedly elevated in this patient:
A. Secretin
B. Vasoactive intestinal peptide
C. Cholecystokinin
D. Gastrin (Correct Answer)
E. Motilin
Explanation: ***Gastrin***
- A pancreatic mass (likely a **gastrinoma**) producing excess **gastrin** leads to Zollinger-Ellison syndrome, characterized by refractory **peptic ulcers** (especially distal to the duodenal bulb) and **diarrhea** due to increased gastric acid.
- The high gastrin levels stimulate parietal cells to secrete an excessive amount of **hydrochloric acid**, overwhelming the neutralizing capacity of the duodenum and causing ulcers.
*Secretin*
- Secretin is released from S cells in the duodenum in response to acid and fatty acids, stimulating **bicarbonate secretion** from the pancreas and bile ducts.
- While secretin can be used diagnostically to confirm gastrinoma (paradoxical increase in gastrin), it is not the primary hormone elevated in this syndrome causing the symptoms.
*Vasoactive intestinal peptide*
- Elevated vasoactive intestinal peptide (VIP) is characteristic of a **VIPoma**, which causes **profuse watery diarrhea** (pancreatic cholera), hypokalemia, and achlorhydria.
- This patient's symptoms include abdominal pain and duodenal ulcers which are not typical for a VIPoma.
*Cholecystokinin*
- **Cholecystokinin (CCK)** is primarily involved in stimulating gallbladder contraction and pancreatic enzyme secretion in response to fats and proteins.
- While it can be produced by some neuroendocrine tumors, it does not typically cause the constellation of symptoms (refractory duodenal ulcers, severe diarrhea) seen in this patient.
*Motilin*
- Motilin is responsible for initiating the **migrating motor complex** during the interdigestive phase, promoting gut motility.
- While altered motility can contribute to diarrhea, motilin is not typically associated with ulcer formation or pancreatic islet cell tumors causing gastric hypersecretion.
Question 16: A 16-year-old male presents to his pediatrician concerned that he is not maturing like his friends. He has a history of cleft palate status-post multiple surgeries and asthma treated with budesonide and albuterol. He is a good student and is very active on his school’s gymnastics team. His mother is also concerned that her son does not understand good personal hygiene. She reports that he always forgets to put on deodorant. When asked about this, he says he does not notice any body odor on himself or others. His temperature is 99.2°F (37.3°C), blood pressure is 105/70 mmHg, pulse is 70/min, and respirations are 18/min. His height and weight are in the 20th and 25th percentiles, respectively. On physical examination, his penis and testicles show no evidence of enlargement. He has no pubic or axillary hair. Which of the following sets of hormone levels is most likely to be found in this patient?
A. Decreased testosterone, increased FSH, increased LH, increased GnRH
B. Normal testosterone, normal FSH, normal LH, normal GnRH
C. Increased testosterone, decreased FSH, decreased LH, decreased GnRH
E. Decreased testosterone, normal FSH, normal LH, normal GnRH
Explanation: ***Decreased testosterone, decreased FSH, decreased LH, decreased GnRH***
- The patient's **lack of secondary sexual characteristics** (no pubic or axillary hair, undeveloped genitals) and reported **anosmia** (cannot notice body odor) are classic signs of **Kallmann syndrome**.
- Kallmann syndrome is a form of **hypogonadotropic hypogonadism**, characterized by impaired GnRH production from the hypothalamus, leading to low FSH, LH, and consequently low testosterone.
*Decreased testosterone, increased FSH, increased LH, increased GnRH*
- This hormonal pattern indicates **primary hypogonadism**, where the testes are failing to produce testosterone, but the pituitary and hypothalamus are working correctly and attempting to stimulate the testes.
- This patient's clinical presentation, specifically the absence of secondary sexual characteristics and anosmia, is not consistent with primary testicular failure.
*Normal testosterone, normal FSH, normal LH, normal GnRH*
- This hormonal profile would indicate **normal pubertal development**, which clearly contradicts the patient's presentation of delayed puberty, undeveloped genitals, and lack of secondary sexual characteristics.
- Such levels would be expected in a typical 16-year-old male who has undergone puberty.
*Increased testosterone, decreased FSH, decreased LH, decreased GnRH*
- This pattern is seen in conditions with **exogenous androgen administration** or **androgen-producing tumors**, leading to negative feedback on the hypothalamus and pituitary.
- This is inconsistent with the patient's clinical picture of delayed puberty and undeveloped sexual characteristics.
*Decreased testosterone, normal FSH, normal LH, normal GnRH*
- This specific combination is unusual and does not fit a typical endocrine disorder causing delayed puberty. If testosterone is low, FSH and LH would typically be elevated in primary hypogonadism or decreased in secondary/tertiary hypogonadism.
- It does not explain the patient's complete lack of pubertal development associated with anosmia.
Question 17: A 55-year-old woman with rheumatoid arthritis comes to the physician because of a 3-month history of worsening fatigue and dyspnea. She has felt short-of-breath when walking up the stairs to her apartment. Menopause occurred 5 years ago. Her medications are methotrexate and folic acid supplementation. Physical examination shows conjunctival pallor, tenderness of bilateral wrists and knees, and ulnar deviation of the fingers. Her hematocrit is 27%, mean corpuscular volume is 84 μm3, and serum ferritin is 375 ng/mL. Which of the following has most likely contributed to the patient's current symptoms?
A. Increased release of iron from macrophages
B. Increased activity of ferroportin-1 in enterocytes
C. Increased production of reticulocytes in bone marrow
D. Increased concentration of transferrin in serum
E. Increased release of hepcidin by hepatocytes (Correct Answer)
Explanation: ***Increased release of hepcidin by hepatocytes***
- The patient has anemia of chronic disease (ACD) due to rheumatoid arthritis, characterized by fatigue, dyspnea, pallor, a low hematocrit (27%), and normal MCV (84 μm3), with an elevated ferritin (375 ng/mL).
- **Hepcidin**, released by the liver in response to inflammation, blocks iron release from macrophages and enterocytes, leading to iron sequestration and reduced iron availability for erythropoiesis.
*Increased release of iron from macrophages*
- In ACD, **iron is sequestered** within macrophages, and its release is *decreased* due to hepcidin's action on ferroportin.
- This leads to reduced circulating iron, despite normal or elevated iron stores.
*Increased activity of ferroportin-1 in enterocytes*
- **Ferroportin-1** activity in enterocytes is *reduced* by hepcidin in ACD, leading to decreased iron absorption from the diet.
- This contributes to the functional iron deficiency seen in chronic inflammation.
*Increased production of reticulocytes in bone marrow*
- Anemia of chronic disease is characterized by **impaired erythropoiesis**, not increased reticulocyte production.
- The bone marrow’s response to anemia is blunted due to decreased iron availability and suppression by inflammatory cytokines.
*Increased concentration of transferrin in serum*
- In ACD, **transferrin levels are typically decreased** (or normal), which is in contrast to iron deficiency anemia where transferrin is usually elevated to compensate for low iron.
- Hepcidin's action reduces the overall iron carrying capacity.
Question 18: A 42-year-old woman presents with fatigue. She says that her symptoms have gradually onset after she recently had a total thyroidectomy due to Graves' disease. Past medical history is otherwise unremarkable. The patient is afebrile, and her vital signs are within normal limits. Physical examination is unremarkable. Laboratory findings are significant for the following:
Potassium 4.2 mEq/L
Calcium 7.8 mg/dL
Chloride 102 mEq/L
Vitamin D3 8 ng/mL (ref range: 25–80 ng/mL)
A deficiency of which of the following is the most likely cause of this patient's symptoms?
A. Parathyroid hormone (PTH) (Correct Answer)
B. Thyroid-stimulating hormone (TSH)
C. 1-alpha-hydroxylase
D. Calcitonin
E. 25-hydroxycholecalciferol
Explanation: **Parathyroid hormone (PTH)**
- The patient's **hypocalcemia** (calcium 7.8 mg/dL) combined with a history of recent **total thyroidectomy** suggests accidental removal or damage to the **parathyroid glands**, leading to **hypoparathyroidism**.
- Without sufficient PTH, the body cannot effectively raise **serum calcium** by stimulating bone resorption, increasing renal calcium reabsorption, and activating **vitamin D**.
*Thyroid-stimulating hormone (TSH)*
- While thyroidectomy affects thyroid hormone production, the primary issue indicated by the low calcium is related to **parathyroid function**, not typically TSH.
- TSH levels would be relevant for assessing **hypothyroidism** but do not directly explain the acute **hypocalcemia** post-surgery.
*1-alpha-hydroxylase*
- A deficiency in **1-alpha-hydroxylase** would lead to impaired activation of **vitamin D**, resulting in low levels of **calcitriol** (1,25-dihydroxyvitamin D).
- This typically causes malabsorption of calcium from the gut, but the immediate and severe hypocalcemia after thyroidectomy points more directly to issues with PTH secretion.
*Calcitonin*
- **Calcitonin** is produced by the thyroid gland and acts to lower serum calcium, but a deficiency (e.g., after thyroidectomy) would lead to **hypercalcemia**, not hypocalcemia, and its role in calcium homeostasis is minor compared to PTH and vitamin D.
- Thyroidectomy would remove calcitonin-producing *C cells*, which would contribute to **raised calcium levels**, rather than the observed **low calcium levels**.
*25-hydroxycholecalciferol*
- The patient has low **25-hydroxycholecalciferol** (vitamin D3), but this is a common insufficiency and typically leads to chronic, less severe hypocalcemia.
- The acute onset of symptoms and hypocalcemia *immediately after thyroidectomy* makes the loss of PTH the more direct and likely cause, as PTH is essential for activating existing vitamin D and directly regulating calcium.
Question 19: A 57-year-old man is rushed to the emergency department by ambulance after being found on the floor gasping for air with severe shortness of breath by his partner. Past medical history is significant for congestive heart failure, hypertension, and hyperlipidemia. He normally takes chlorthalidone, atorvastatin, metoprolol, and valsartan, but he recently lost his job and insurance and has not been able to afford his medication in 2 months. Upon arrival at the hospital, his blood pressure is 85/50 mm Hg, heart rate is 110/min, respiratory rate is 24/min, oxygen saturation 90% on 100% oxygen, and temperature is 37.7°C (99.9°F). On physical exam, he appears obese and can only answer questions in short gasps as he struggles to breathe. His heart rate is tachycardic with a mildly irregular rhythm and auscultation of his lungs reveal crackles in the lower lobes, bilaterally. Which of the following physiologic changes is currently seen in this patient?
A. ↑ Plasma renin and angiotensin II activity, ↑ blood pressure, normal renal perfusion pressure, ↓ serum pH
B. ↓ Plasma renin and angiotensin II activity, ↑ blood pressure, normal renal perfusion pressure, ↑ serum pH
C. ↑ Plasma renin and angiotensin II activity, ↓ blood pressure, ↓ renal perfusion pressure, ↑ serum pH (Correct Answer)
D. Normal plasma renin and angiotensin II activity, ↓ blood pressure, ↓ renal perfusion pressure, ↓ serum pH
E. ↑ Plasma renin and angiotensin II activity, ↑ blood pressure, ↓ renal perfusion pressure, ↑ serum pH
Explanation: ***↑ Plasma renin and angiotensin II activity, ↓ blood pressure, ↓ renal perfusion pressure, ↑ serum pH***
- The patient's **hypotension (85/50 mm Hg)** means a decreased **renal perfusion pressure**, which triggers the **renin-angiotensin-aldosterone system (RAAS)**, leading to **increased renin and angiotensin II activity** to try and raise blood pressure.
- The patient's **gasping for air** and **struggle to breathe** indicate significant respiratory distress, leading to **hyperventilation** (increased respiratory rate of 24/min). This causes an **excessive exhalation of CO2**, resulting in **respiratory alkalosis** (↑ serum pH), which is a common compensatory mechanism in acute heart failure.
*↑ Plasma renin and angiotensin II activity, ↑ blood pressure, normal renal perfusion pressure, ↓ serum pH*
- This option incorrectly states **elevated blood pressure** and **normal renal perfusion pressure**, which contradicts the patient's measured hypotensive state.
- The patient's presentation with acute respiratory distress and compensatory hyperventilation is unlikely to result in **acidosis (↓ serum pH)**, but rather alkalosis.
*↓ Plasma renin and angiotensin II activity, ↑ blood pressure, normal renal perfusion pressure, ↑ serum pH*
- This option incorrectly suggests **decreased renin and angiotensin II activity** despite the patient's low blood pressure, which would typically activate the RAAS.
- It also includes **elevated blood pressure** and **normal renal perfusion pressure**, which are inconsistent with the patient's clinical presentation of hypotension and heart failure exacerbation.
*↑ Plasma renin and angiotensin II activity, ↑ blood pressure,↓ renal perfusion pressure, ↑ serum pH*
- This option correctly identifies **increased plasma renin and angiotensin II activity** and **decreased renal perfusion pressure** but incorrectly suggests an **elevated blood pressure**, which is contradictory to the patient's measured blood pressure of 85/50 mm Hg.
- Although the **increased serum pH** is consistent with respiratory alkalosis due to hyperventilation, the incorrect blood pressure makes this option unsuitable.
*Normal plasma renin and angiotensin II activity, ↓ blood pressure, ↓ renal perfusion pressure, ↓ serum pH*
- This option incorrectly states **normal plasma renin and angiotensin II activity**, which would be highly unlikely in a patient with severe hypotension and struggling to maintain blood pressure.
- The patient's **hyperventilation** due to respiratory distress would lead to **respiratory alkalosis (↑ serum pH)**, not a decreased pH (acidosis).
Question 20: A 58-year-old Caucasian woman visits her primary care physician for an annual check-up. She has a history of type 2 diabetes mellitus and stage 3A chronic kidney disease. Her estimated glomerular filtration rate has not changed since her last visit. Today, her parathyroid levels are moderately elevated. She lives at home with her husband and 2 children and works as a bank clerk. Her vitals are normal, and her physical examination is unremarkable. Which of the following explains this new finding?
A. Uremia
B. Acidemia
C. Hyperuricemia
D. Hypercalcemia
E. Phosphate retention (Correct Answer)
Explanation: ***Phosphate retention***
- **Chronic kidney disease** often leads to **phosphate retention** because the damaged kidneys cannot effectively excrete phosphate.
- This elevated phosphate stimulates the parathyroid glands to secrete more **parathyroid hormone (PTH)** as a compensatory mechanism, leading to secondary hyperparathyroidism.
*Uremia*
- While uremia (accumulation of nitrogenous waste products) is a feature of chronic kidney disease, it is not the **direct cause** of elevated parathyroid levels.
- Uremia primarily causes symptoms like fatigue, nausea, and altered mental status, but it doesn't independently trigger PTH release in the same direct manner as phosphate retention or hypocalcemia.
*Acidemia*
- **Metabolic acidosis** is common in chronic kidney disease, but it generally **inhibits** PTH secretion, not stimulates it.
- While it can worsen bone disease, acidemia itself does not explain the primary elevation of parathyroid hormone.
*Hyperuricemia*
- **Hyperuricemia** (elevated uric acid levels) is often associated with chronic kidney disease due to decreased renal excretion of uric acid.
- However, hyperuricemia does not directly cause or explain elevated parathyroid hormone levels.
*Hypercalcemia*
- **Hypercalcemia** would typically **suppress** parathyroid hormone secretion, not elevate it.
- In chronic kidney disease, **hypocalcemia** (due to impaired vitamin D activation and phosphate retention) is more common and would stimulate PTH.